/BPCP.L
BPCP.L Stock - BioPharma Credit PLC
Financial Services|Asset ManagementLSE
$68.40+0.00%
+$0.00 (+0.00%) • Dec 22
78
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.92
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $75.24
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for BPCP.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$67.72 – $69.08
TARGET (TP)$78.66
STOP LOSS$62.93
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.17
52W High$68.40
52W Low$0.64
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $124.46M | $135.74M | $184.25M | $87.97M | $91.35M |
| Gross Profit | $124.46M | $135.74M | $184.25M | $87.97M | $91.35M |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Income | $122.18M | $108.46M | $182.31M | $84.96M | $89.14M |
| Net Income | $122.18M | $108.45M | $182.31M | $84.96M | $89.14M |
| Net Margin | 98.2% | 79.9% | 99.0% | 96.6% | 97.6% |
| EPS | $0.10 | $0.08 | $0.13 | $0.06 | $0.06 |
Company Overview
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in Exeter, the United Kingdom.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
BPCP.LBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$0.03
Q3 2025
EPS Surprise History
Q4 21
No data
Q2 22
No data
Q4 22
No data
Q2 23
No data
Q1 24
No data
Q3 24
No data
Q1 25
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 23, 2026 | — | — | — | — |
Q3 2025 | Sep 22, 2025 | — | $0.03 | — | — |
Q1 2025 | Mar 25, 2025 | — | $0.03 | — | — |
Q3 2024 | Sep 24, 2024 | — | $0.05 | — | — |
Q1 2024 | Mar 27, 2024 | — | $0.02 | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.04 | — | — |
Q4 2022 | Dec 31, 2022 | — | $0.07 | — | — |
Q2 2022 | Jun 30, 2022 | — | $0.04 | — | — |
Q4 2021 | Dec 31, 2021 | — | $0.02 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.02 | — | — |
Q4 2020 | Dec 31, 2020 | — | $0.03 | — | — |
Q2 2020 | Jun 30, 2020 | — | $0.02 | — | — |
Q4 2019 | Dec 31, 2019 | — | $0.02 | — | — |
Q2 2019 | Jun 30, 2019 | — | $0.05 | — | — |
Q4 2018 | Dec 31, 2018 | — | $0.02 | — | — |
Q2 2018 | Jun 30, 2018 | — | $0.03 | — | — |
Q4 2017 | Dec 31, 2017 | — | $0.02 | — | — |
Q2 2017 | Jun 30, 2017 | — | $0.01 | — | — |
Latest News
Loading news...
Frequently Asked Questions about BPCP.L
What is BPCP.L's current stock price?
BioPharma Credit PLC (BPCP.L) is currently trading at $68.40 per share. The stock has moved +0.00% today.
What is the analyst price target for BPCP.L?
No analyst price targets are currently available for this stock.
What sector is BioPharma Credit PLC in?
BioPharma Credit PLC operates in the Financial Services sector, specifically within the Asset Management industry. The company is traded on the LSE exchange.
What is BPCP.L's market cap?
BioPharma Credit PLC has a market capitalization of $0.80 billion, making it a small-cap company.
Does BPCP.L pay dividends?
No, BioPharma Credit PLC does not currently pay a dividend to shareholders.
Similar Stocks
Financial Services SectorCORD.L
Cordiant Digital Infrastructure Limited
$104.00
Mkt Cap: $79.6B
FEML.L
Fidelity Emerging Markets Limited
$1036.00
Mkt Cap: $66.9B
GROW.L
Molten Ventures Plc
$491.20
Mkt Cap: $85.9B
IEM.L
Impax Environmental Markets plc
$397.00
Mkt Cap: $76.6B
MTRO.L
Metro Bank PLC
$120.40
Mkt Cap: $81.1B
NBPE.L
NB Private Equity Partners Limited
$1620.00
Mkt Cap: $70.7B
POLN.L
Pollen Street Group Limited
$936.00
Mkt Cap: $56.3B
RICA.L
Ruffer Investment Company Limited
$294.00
Mkt Cap: $87.1B
SAIN.L
The Scottish American Investment Company PLC
$507.00
Mkt Cap: $83.7B
SYNC.L
Syncona Limited
$93.50
Mkt Cap: $56.9B
Explore stocks similar to BPCP.L for comparison